RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC.
2.61
-0.270 -10.345%
Share volume: 417,539
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.88
-0.27
-0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 13.497 M | 8.053 M | 7.630 M | 7.077 M | 11.635 M | 14.333 M | |
| Current Assets | 12.717 M | 7.233 M | 6.810 M | 6.257 M | 10.815 M | 13.513 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 11.974 M | 6.178 M | 5.559 M | 5.289 M | 10.364 M | 13.183 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 779.602 K | 819.721 K | 819.721 K | 819.721 K | 819.721 K | 819.721 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 13.497 M | 8.053 M | 7.630 M | 7.077 M | 11.635 M | 14.333 M | |
| Total liabilities | 14.842 M | 14.094 M | 17.612 M | 11.537 M | 12.094 M | 9.783 M | |
| Total current liabilities | 14.492 M | 13.944 M | 17.534 M | 11.509 M | 12.077 M | 9.738 M | |
| Accounts Payable | 5.720 M | 4.693 M | 8.778 M | 4.721 M | 4.969 M | 5.432 M | |
| Other liabilities | 350.478 K | 150.205 K | 77.884 K | 27.816 K | 16.690 K | 44.506 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 350.478 K | 150.205 K | 77.884 K | 27.816 K | 16.690 K | 44.506 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.346 M | -6.042 M | -9.982 M | -4.460 M | -459.147 K | 4.550 M | |
| Common stock | 140.442 M | 143.606 M | 148.032 M | 166.246 M | 176.300 M | 185.320 M | |
| Retained earnings | -141.788 M | -149.648 M | -158.014 M | -170.706 M | -176.760 M | -180.770 M |